Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
9 June 2023
| m 01:50 | Bortezomib (Velcade) diffhist +187 Jwarner talk contribs | ||||
| m 01:49 | Lenvatinib (Lenvima) diffhist +283 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 01:48 | Trametinib (Mekinist) diffhist +151 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 01:47 | Dabrafenib (Tafinlar) diffhist +178 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 01:43 | Ketoconazole (Nizoral) diffhist +3 Jwarner talk contribs | ||||
| m 01:43 | Galeterone (TOK-001) diffhist -39 Jwarner talk contribs | ||||
| m 01:42 | Orteronel (TAK-700) diffhist +20 Jwarner talk contribs | ||||
| N 01:42 | Category:CYP17 inhibitors diffhist +41 Jwarner talk contribs Created page with "Category:Steroid synthesis inhibitors" | ||||
| m 01:42 | Abiraterone (Zytiga) diffhist +178 Jwarner talk contribs | ||||
| m 01:39 | Olaparib (Lynparza) diffhist +209 Jwarner talk contribs | ||||
|
|
m 01:37 | Inotuzumab ozogamicin (Besponsa) 2 changes history +236 [Jwarner (2×)] | |||
| m |
|
01:37 (cur | prev) +2 Jwarner talk contribs →History of changes in PMDA indication | |||
| m |
|
01:37 (cur | prev) +234 Jwarner talk contribs | |||
| m 01:36 | Atezolizumab (Tecentriq) diffhist +116 Jwarner talk contribs | ||||
|
|
m 01:34 | Pembrolizumab (Keytruda) 3 changes history +367 [Jwarner (3×)] | |||
| m |
|
01:34 (cur | prev) +179 Jwarner talk contribs →History of changes in PMDA indication | |||
| m |
|
01:34 (cur | prev) +187 Jwarner talk contribs →History of changes in PMDA indication | |||
| m |
|
01:33 (cur | prev) +1 Jwarner talk contribs →=Non-small cell lung cancer | |||
| m 01:32 | Fulvestrant (Faslodex) diffhist +131 Jwarner talk contribs | ||||
| m 01:30 | Avelumab (Bavencio) diffhist +121 Jwarner talk contribs | ||||
| m 01:30 | Daratumumab (Darzalex) diffhist +128 Jwarner talk contribs | ||||
| m 01:29 | Palbociclib (Ibrance) diffhist +127 Jwarner talk contribs | ||||
| m 01:28 | Nivolumab (Opdivo) diffhist +163 Jwarner talk contribs →Gastric cancer | ||||
| m 01:27 | Ceritinib (Zykadia) diffhist +182 Jwarner talk contribs | ||||
| m 01:26 | Lanreotide (Somatuline) diffhist +219 Jwarner talk contribs | ||||
| m 01:25 | Romidepsin (Istodax) diffhist +178 Jwarner talk contribs | ||||
|
|
m 01:25 | Pralatrexate (Folotyn) 2 changes history +166 [Jwarner (2×)] | |||
| m |
|
01:25 (cur | prev) +10 Jwarner talk contribs →Also known as | |||
| m |
|
01:24 (cur | prev) +156 Jwarner talk contribs | |||
| N 01:24 | Category:PMDA approved in 2017 diffhist +32 Jwarner talk contribs Created page with "Category:PMDA approved drugs" | ||||
| m 01:23 | Regorafenib (Stivarga) diffhist +191 Jwarner talk contribs | ||||
| m 01:22 | Crizotinib (Xalkori) diffhist +190 Jwarner talk contribs | ||||
| m 01:21 | Rituximab (Rituxan) diffhist +150 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 01:19 | Olanzapine (Zyprexa) diffhist +257 Jwarner talk contribs | ||||
| m 01:18 | Cyclosporine diffhist +154 Jwarner talk contribs | ||||
| m 01:17 | Eltrombopag (Promacta) diffhist +175 Jwarner talk contribs | ||||
8 June 2023
| m 20:54 | Trastuzumab deruxtecan (Enhertu) diffhist +10 Jwarner talk contribs →Breast cancer | ||||
| m 20:52 | Bendamustine diffhist +91 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 20:51 | Cytarabine (Ara-C) diffhist +136 Jwarner talk contribs | ||||
| m 20:50 | Cyclophosphamide (Cytoxan) diffhist +95 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 20:50 | Fludarabine (Fludara) diffhist +96 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 20:49 | Etoposide (Vepesid) diffhist +136 Jwarner talk contribs | ||||
| m 20:48 | Rituximab (Rituxan) diffhist +126 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 20:47 | Thiotepa (Thioplex) diffhist +193 Jwarner talk contribs | ||||
| m 20:46 | Apalutamide (Erleada) diffhist +140 Jwarner talk contribs | ||||
| m 20:45 | Temozolomide (Temodar) diffhist +176 Jwarner talk contribs | ||||
| m 20:44 | Dacomitinib (Vizimpro) diffhist +204 Jwarner talk contribs | ||||
| m 20:44 | Binimetinib (Mektovi) diffhist +133 Jwarner talk contribs | ||||
| m 20:43 | Encorafenib (Braftovi) diffhist +133 Jwarner talk contribs | ||||
| m 20:42 | Pembrolizumab (Keytruda) diffhist +536 Jwarner talk contribs | ||||
| m 20:40 | Pertuzumab (Perjeta) diffhist +82 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 20:39 | Fluorouracil (5-FU) diffhist +169 Jwarner talk contribs | ||||
| m 20:38 | Levoleucovorin (Fusilev) diffhist +221 Jwarner talk contribs | ||||